Neuphoria Therapeutics
Price & Volume
Stats
See more52W Range | $2.12-$15.24 |
Market Cap | $96.4M |
Shares Short | 221,511 |
Financials
See moreRevenue (12 Mos) | $662,715 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $662,715 |
Diluted EPS | $10.93 |
News
See moreYahoo Finance • 17 days ago
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
Yahoo Finance • last month
Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
About
CEO | Dr. Spyridon Papapetropoulos M.D., Ph.D. |
Address | 100 Summit Dr, Burlington, MA, United States, 01803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
